Clinical activity of nivolumab in patients with non-clear cell renal cell carcinomaVadim S. Koshkin, Brian I. Rini, Pedro C. Barata et al.|Journal for ImmunoTherapy of Cancer|2018Cited by 184
Snail promotes resistance to enzalutamide through regulation of androgen receptor activity in prostate cancerKathryn E. Ware, Andrew J. Armstrong, Jing Li et al.|Oncotarget|2016Cited by 55
Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancerTian Zhang, Andrew J. Armstrong, Anika Agarwal et al.|Biomarker Research|2021Cited by 49
Alterations of gut microbiota and serum bile acids are associated with parenteral nutrition-associated liver diseaseNan Wang, Ying Wang, Jiazheng Wang et al.|Journal of Pediatric Surgery|2020Cited by 19
Combination antiangiogenic tyrosine kinase inhibition and anti‐PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomesAndrew Leonard Laccetti, Matthew T. Campbell, Benjamin Garmezy et al.|Cancer Medicine|2021Cited by 19